MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma

Li Ren Kong(National University of Singapore), Boon Cher Goh(National University of Singapore)
Molecular Cancer Therapeutics
May 4, 2015
Cited by 51


Related Papers